• News News
News

We are honor to share the great News from intel AIIP partnership

2021/07/22


 

We are honor to share the great News from intel AIIP partnership

The application that develop with Onyx’s Accel series with sever grade processor and training with OpenVINO toolkit. We are proud to share our successful story

 

With medication errors costing USD 42 billion worldwide,1 Onyx Healthcare created the AI Medicine Recognition Device. The solution automates the process of identifying medicine, making it possible to dispense medication quickly with a high accuracy rate. Enabled by the Intel® Distribution of OpenVINO™ toolkit, Intel® Movidius™ Myriad™ X VPUs, and an Intel® Xeon® E3 processor, the Onyx solution is designed to streamline workflows for nurses and pharmacists and help improve patient care. By using machine vision and artificial intelligence (AI) to quickly and seamlessly identify medications that might otherwise look remarkably similar to the human eye, the Onyx solution can help reduce medical errors that cause up to a quarter of a million annual deaths in the US.2Though still a prototype, the Onyx AI Medicine Recognition Device automates the “five rights” of medication administration—right patient, right drug, right dose, right route, and right time—into a single-scan workflow that simplifies the duties of nurses and other healthcare providers, allowing personnel to focus more on patient care and other sensitive tasks. Onyx Healthcare Inc. is a medical IT company that provides innovative, customer-centric medical PC products and services.

 

 

 

Intel-Solution Brief Ai Machine Vision Medicine Recognition
Onyx ldentifies Medications for More-Efficient Hospital and Pharmacy Dispensingd

 

 

We use cookies to provide the services and features offered on our website, and to improve our user experience. By using this website, you consent to the use of cookies.